This trial is studying a potential treatment for Alzheimer's disease that involves training people to change their brain function.
1 Primary · 3 Secondary · Reporting Duration: From baseline to 12 weeks of treatment
Experimental Treatment
Non-Treatment Group
112 Total Participants · 2 Treatment Groups
Primary Treatment: Neurofeedback · Has Placebo Group · N/A
Age 50 - 85 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: